
An experimental hormone therapy pill can effectively stall the progression of breast cancer, even in older patients whose tumors have mutated to make such therapy less effective, new trial results show. The drug elacestrant reduced the risk of breast cancer progression and death by 30% in postmenopausal patients whose cancers were fueled by the female… read on > read on >